Aflac Incorporated (AFL) Stock

AFL has increased its quarterly dividend to 58 cents per share, showing that the company is in a good financial state and is wisely managing its capital.

COLUMBUS, Ga., Dec. 2, 2024 /PRNewswire/ -- Aflac Incorporated (NYSE: AFL) has announced that its Board of Directors has approved a dividend of $0.58 per share for the first quarter. This dividend will be paid on March 3, 2025, to shareholders who are on record as of the end of business on February 19, 2025.

AFL is expected to grow due to increased sales in the U.S. and Japan, along with better operational efficiency.

Thanks to Aflac, young cancer patients in Northern California now have a soft robotic friend to help them feel better during their treatment. These comforting companions were donated to support the children as they go through their difficult journey.

COLUMBUS, Ga., Nov. 21, 2024 /PRNewswire/ -- Aflac Incorporated (NYSE: AFL) has announced that it will stream its yearly Financial Analysts Briefing on December 3, 2024, beginning at 8:00 a.m.

Aflac (AFL) has received a Zacks Rank #2 (Buy) upgrade, indicating increased confidence in the company's potential earnings. This could lead to a rise in the stock price soon.

The 14th annual Aflac WorkForces Report reveals that U.S. Hispanic employees experience burnout at nearly double the rate of their non-Hispanic counterparts. This situation presents a challenge for both American employers and their workers, as workplace stress and burnout continue to rise.

Aflac has announced the appointment of JR Shamley as the new senior vice president for National Account Business Development and Growth Solutions. With 30 years of experience in the insurance industry, he will use his knowledge in carrier and benefits consulting to enhance Aflac's distribution model and promote profitable growth. Aflac is a top provider of supplemental health insurance in the United States.

Aflac has been upgraded to a Buy rating from my previous hold rating a year ago, thanks to growth and retention of policies in Q3, even though there was a loss in net earnings. While the stock is close to a 10-year high, it remains undervalued compared to important competitors based on forward P/E and trailing P/B ratios. The trend of increasing dividends is expected to remain strong.